Measles, Mumps, and Rubella - Centers for Disease Control and ...

54 MMWR May 22, 1998155. Ekbom A, Daszak P, Kraaz W, Wakefield AJ. Crohn’s disease after in-utero measles exposure.Lancet 1996;348:515–7.156. Thompson NP, Montgomery SM, Pounder RE, Wakefield AJ. Is measles vaccination a riskfactor for inflammatory bowel disease? Lancet 1995;345:1071–4.157. Liu Y, van Kruiningen HJ, West AB, Cartun RW, Cortot A, Colombel JF. Immunocytochemicalevidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn’s disease. Gastroenterology1995;108:1396–404.158. Iizuka M, Nakagomi O, Chiba M, Ueda S, Masamune O. Absence of measles virus in Crohn’sdisease [letter]. Lancet 1995;345:199.159. Patriarca PA, Beeler JA. Measles vaccination and inflammatory bowel disease [comment].Lancet 1995;345:1062–3.160. Farrington P, Miller E. Measles vaccination as a risk factor for inflammatory bowel disease[letter]. Lancet 1995;345:1362.161. MacDonald TT. Measles vaccination as a risk factor for inflammatory bowel disease [letter].Lancet 1995;345:1363–4.162. Miller D, Renton A. Measles vaccination as a risk factor for inflammatory bowel disease [letter].Lancet 1995;345:1363.163. Chen RT, DeStefano F. Vaccine adverse events: causal or coincidental [comment]. Lancet1998;351:611–2.164. Feeney M, Clegg A, Winwood P, Snook J. A case-control study of measles vaccination andinflammatory bowel disease. Lancet 1997;350:764-6.165. Haga Y, Funakoshi O, Kuroe K, et al. Absence of measles viral genomic sequence in intestinaltissues from Crohn’s disease by nested polymerase chain reaction. Gut 1996;38:211–5.166. Peltola H, Heinonen OP. Frequency of true adverse reactions to measles-mumps-rubella vaccine.A double-blind placebo-controlled trial in twins. Lancet 1986;1:939–42.167. Nieminen U, Peltola H, Syrjala MT, Makipernaa A, Kekomaki R. Acute thrombocytopenic purpurafollowing measles, mumps and rubella vaccination. A report on 23 patients. Acta Paediatr1993;82:267–70.168. Farrington P, Pugh S, Colville A, et al. A new method for active surveillance of adverse eventsfrom diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet 1995;345: 567–9.169. Bottiger M, Christenson B, Romanus V, Taranger J, Strandell A. Swedish experience of twodose vaccination programme aiming at eliminating measles, mumps, and rubella. Br Med JClin Res Ed. 1987;295:1264–7.170. Koch J, Leet C, McCarthy R, et al. Adverse events temporally associated with immunizingagents—1987 report. Canada Diseases Weekly Report 1989;15:151–8.171. Jonville-Bera A, Autret E, Galy-Eyraud C, Hessel L. Thrombocytopenic purpura after measles,mumps and rubella vaccination: a retrospective survey by the French regional pharmacovigilancecentres and Pasteur-Merieux Serums et Vaccins. Pediatr Infect Dis J 1996;15:44–8.172. Beeler J, Varricchio F, Wise R. Thrombocytopenia after immunization with measles vaccines:review of the vaccine adverse events reporting system (1990 to 1994). Pediatr Infect Dis J1996;15:88–90.173. Bayer WL, Sherman FE, Michaels RH, et al. Purpura in congenital and acquired rubella. N EnglJ Med 1965;273:1362–6.174. Drachtman RA, Murphy S, Ettinger LJ, et al. Exacerbation of chronic thrombocytopenic purpurafollowing measles-mumps-rubella immunization. Arch Pediatr Adolesc Med 1994;148:326–7.175. Vlacha V, Forma EN, Miron D, Peter G. Recurrent thrombocytopenic purpura after repeatedmeasles-mumps-rubella vaccination. Pediatrics 1996;97:738–9.176. Institute of Medicine. Measles and mumps vaccines. In: Stratton KR, Howe CJ, Johnston RB,eds. Adverse events associated with childhood vaccines. Evidence bearing on causality. Washington,DC: National Academy Press, 1994:130–5.177. Black S, Shinefield H, Ray P, et al. Risk of hospitalization because of aseptic meningitis aftermeasles-mumps-rubella vaccination in one- to two-year-old children: an analysis of the VaccineSafety Datalink (VSD) Project. Pediatr Infect Dis J 1997;16:500–3.178. Miller E, Goldacre M, Pugh S, et al. Risk of aseptic meningitis after measles, mumps, andrubella vaccine in UK children. Lancet 1993;341:979–95.